<font color="red">Inverse_1</font> <font color="red">Effect_2</font> of Fluoxetine on <font color="red">Medial_2</font> <font color="red">Prefrontal_2</font> <font color="red">Cortex_2</font> <font color="red">Activation_2</font> During Reward Reversal in <font color="red">ADHD_1</font> <font color="red">and_1</font> <font color="red">Autism_1</font> <font color="red">._1</font> 
<br>
<br> <font color="red">Attention_1</font> <font color="red">deficit_1</font> <font color="red">hyperactivity_1</font> <font color="red">disorder_1</font> <font color="red">(_1</font> <font color="red">ADHD_1</font> <font color="red">)_1</font> <font color="red">and_1</font> <font color="red">autism_1</font> <font color="red">spectrum_1</font> <font color="red">disorder_1</font> <font color="red">(_1</font> <font color="red">ASD_1</font> <font color="red">)_1</font> share <font color="red">brain_1</font> <font color="red">function_1</font> <font color="red">abnormalities_1</font> during cognitive flexibility . Serotonin is involved in both disorders , and <font color="red">selective_1</font> <font color="red">serotonin_1</font> <font color="red">reuptake_1</font> <font color="red">inhibitors_1</font> <font color="red">(_1</font> <font color="red">SSRIs_1</font> <font color="red">)_1</font> can modulate <font color="red">cognitive_1</font> <font color="red">flexibility_1</font> and improve <font color="red">behavior_1</font> in both disorders . Thus , this study <font color="red">investigates_1</font> <font color="red">shared_2</font> <font color="red">and_2</font> <font color="red">disorder_2</font> <font color="red">-_2</font> <font color="red">specific_2</font> <font color="red">brain_2</font> <font color="red">dysfunctions_2</font> <font color="red">in_1</font> <font color="red">these_1</font> <font color="red">2_1</font> <font color="red">disorders_1</font> <font color="red">during_1</font> <font color="red">reward_1</font> <font color="red">reversal_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">the_1</font> <font color="red">acute_1</font> <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">an_1</font> <font color="red">SSRI_1</font> <font color="red">on_1</font> <font color="red">these_1</font> <font color="red">._1</font> Age - matched boys with <font color="red">ADHD_1</font> ( 15 ) , ASD ( 18 ) , and controls ( 21 ) were compared with <font color="red">functional_1</font> <font color="red">magnetic_1</font> <font color="red">resonance_1</font> <font color="red">imaging_1</font> <font color="red">(_1</font> <font color="red">fMRI_1</font> <font color="red">)_1</font> during a reversal task . Patients were <font color="red">scanned_1</font> twice , under either an acute dose of Fluoxetine or placebo in a double - blind , placebo - controlled randomized design . <font color="red">Repeated_1</font> <font color="red">-_1</font> <font color="red">measures_1</font> <font color="red">analyses_1</font> <font color="red">within_1</font> <font color="red">patients_1</font> <font color="red">assessed_2</font> <font color="red">drug_4</font> <font color="red">effects_4</font> <font color="red">._4</font> <font color="red">Patients_1</font> <font color="red">under_1</font> <font color="red">each_1</font> <font color="red">drug_1</font> <font color="red">condition_1</font> <font color="red">were_1</font> <font color="red">compared_1</font> <font color="red">with_1</font> <font color="red">controls_1</font> <font color="red">to_1</font> <font color="red">assess_1</font> <font color="red">normalization_2</font> <font color="red">effects_2</font> <font color="red">._2</font> fMRI data showed that , under placebo , ASD boys <font color="red">underactivated_1</font> <font color="red">medial_2</font> <font color="red">prefrontal_2</font> <font color="red">cortex_2</font> <font color="red">(_2</font> <font color="red">mPFC_2</font> <font color="red">)_2</font> <font color="red">,_2</font> compared with control and <font color="red">ADHD_1</font> boys . Both patient groups shared <font color="red">decreased_1</font> <font color="red">precuneus_1</font> <font color="red">activation_1</font> <font color="red">._1</font> Under Fluoxetine , <font color="red">mPFC_2</font> <font color="red">activation_2</font> <font color="red">was_1</font> <font color="red">up_1</font> <font color="red">-_1</font> <font color="red">regulated_1</font> <font color="red">and_1</font> <font color="red">normalized_1</font> <font color="red">in_1</font> <font color="red">ASD_1</font> boys relative to controls , but <font color="red">down_1</font> <font color="red">-_1</font> <font color="red">regulated_1</font> <font color="red">in_1</font> <font color="red">ADHD_1</font> <font color="red">boys_1</font> relative to placebo , which was concomitant with <font color="red">worse_1</font> <font color="red">task_2</font> <font color="red">performance_2</font> <font color="red">in_2</font> <font color="red">ADHD_2</font> <font color="red">._2</font> Fluoxetine therefore has <font color="red">inverse_1</font> <font color="red">effects_1</font> <font color="red">on_1</font> <font color="red">mPFC_2</font> <font color="red">activation_2</font> <font color="red">in_2</font> <font color="red">ASD_2</font> <font color="red">and_2</font> <font color="red">ADHD_2</font> <font color="red">during_1</font> <font color="red">reversal_1</font> <font color="red">learning_1</font> <font color="red">,_1</font> <font color="red">suggesting_1</font> <font color="red">dissociated_1</font> <font color="red">underlying_1</font> <font color="red">serotonin_1</font> <font color="red">abnormalities_1</font> <font color="red">._1</font>